期刊文献+

补骨脂二氢黄酮甲醚诱导HepaRG细胞损伤机制探讨 被引量:7

Study on mechanism of HepaRG cell injury induced by bavachinin
下载PDF
导出
摘要 目的利用HepaRG细胞,探讨补骨脂二氢黄酮甲醚毒性剂量及其毒性作用机制。方法 MTT法确定毒性及剂量。以浓度为6.25、12.5、25μmol·L^(-1)的补骨脂二氢黄酮甲醚作用于细胞24 h后,首先利用Hoechst 33342/PI及LDH的方法检测细胞死亡,并检测凋亡相关蛋白Bax、Bcl-2、caspase-3活性。通过检测线粒体膜电位、ATP含量、线粒体膜通道开放孔开放性及细胞色素C的含量,观察其对线粒体损伤的影响。结果补骨脂二氢黄酮甲醚给药24 h后,凋亡蛋白Bax/Bcl-2比例、caspase-3活性随药物浓度增大而增加,在6.25~25μmol·L^(-1)时,其凋亡率呈现明显的剂量依赖性,但在25μmol·L^(-1)时细胞以坏死为主。作用24 h后线粒体损伤相关指标明显加剧。结论补骨脂二氢黄酮甲醚作用于HepaRG细胞后通过损伤线粒体诱导细胞凋亡和坏死。 Aim To probe into the bavachinin toxic mechanisms in HepaRG cells.Methods MTT assay was used to determine toxicity and dose.After treated with 6.25,12.5 and 25μmol·L-1 bavachinin for 24 h,the cell death was investigated by Hoechst 33342/PI,LDH,caspase-3 activity,and Bax,Bcl-2 expression levels.Mitochondrial damage was detected by mitochondrial membrane potential,ATP content,openness of mitochondrial permeability transition pore and cytochrome C level.Results Bavachinin administration up-regulated Bax/Bcl-2 ratio and caspase-3 activity with increase of drug concentration after 24 h.Apoptotic rate increased in a dose-dependent manner between 6.25 and 25μmol·L-1,but when reached to 25μmol·L-1,cells showed more necrosis.Mitochondrial injury indicators significantly increased after 24h.Conclusion Bavachinin induces HepaRG cell apoptosis and necrosis through mitochondria injury.
作者 季宇彬 王敏 王姗 罗云 孙桂波 孙晓波 JI Yu-bin;WANG Min;WANG Shan;LUO Yun;SUN Gui-bo;SUN Xiao-bo(Research Center on Life Sciences and Environmental Sciences,Harbin University of Commerce,Harbin 150076,China;Pharmacology and Toxicology Center,Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences,Beijing 100193,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2018年第4期544-550,共7页 Chinese Pharmacological Bulletin
基金 国家科技部"重大新药创制"科技重大专项(No2015ZX09501004-001-003) 中国医学科学院医学与健康科技创新工程(No 2017-12M-1-013)
关键词 补骨脂二氢黄酮甲醚 药物性肝损伤 线粒体损伤 凋亡 坏死 细胞色素C bavachinin drug-induced liver injury mitochondrial injury apoptosis necrosis cytochrome C
  • 相关文献

参考文献4

二级参考文献31

  • 1肖芳,钟才高.外源化学物干扰肝细胞线粒体ATP合成体系机制的研究进展[J].中国药理学与毒理学杂志,2010,24(3):232-235. 被引量:3
  • 2Ulrich M. Zanger,Miia Turpeinen,Kathrin Klein,Matthias Schwab.Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation[J].Analytical and Bioanalytical Chemistry.2008(6)
  • 3Olavi Pelkonen,Miia Turpeinen,Jukka Hakkola,Paavo Honkakoski,Janne Hukkanen,Hannu Raunio.Inhibition and induction of human cytochrome P450 enzymes: current status[J].Archives of Toxicology.2008(10)
  • 4Wilkening S,,Stahl F,Bader A,et al.Comparison of pri mary human hepatocytes and hepatoma cell line HepG2with regard totheir biotransformation properties[].Drug Metabolism and Disposition.2003
  • 5Gripon P,Cannie I,Urban S,et al.Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein[].Journal of Virology.2005
  • 6Hantz O,Parent R,Durantel D,et al.Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells[].Journal of General Virology.2009
  • 7Aninat C,Piton A,Glaise D,et al.Expression of cytochromes P450,conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells[].Drug Metabolism and Disposition.2006
  • 8Guillouzo A,Corlu A,Aninat C,et al.human hepatoma HepaRG cells:a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics[].Chemico Biological Interactions.2007
  • 9Turpeinen M,Tolonen A,Chesne C,et al.Functional expression,inhibition and induction of CYP enzymes in HepaRG cells[].Toxicology in Vitro.2009
  • 10Antoun J,,Amet Y,Si mon B,et al.CYP4A11is repressed by retinoic acid in human liver cells[].FEBS Letters.2006

共引文献34

同被引文献109

引证文献7

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部